Kazakhstan’s domestic pharmaceutical
production is on the rise. Since the beginning of the year, it has grown 18
percent up to 124 billion tenge. According to the Ministry of Health, 47
long-term contracts have been signed to support local manufacturers in
supplying drugs, with plans to finalize 79 more agreements next year. By 2025,
production is expected to triple. Currently, three laboratories in Kazakhstan
conduct quality and safety examinations of pharmaceuticals and medical devices.
Additionally, a pilot project launched this year allows electronic
prescriptions via the Social Wallet system, with one in four prescriptions now
processed digitally. Another recent innovation in Kazakhstan’s pharmaceutical
market is the introduction of a labeling and traceability system, which has
processed over 68 million drug packages, 28.5 million of which are now in
circulation.
«Labeling and traceability of medicines have
recently been implemented. This enables tracking the movement of medicines from
manufacturer to patient via barcodes. Previously, this supply chain was not
visible, allowing counterfeit and low-quality medicines to reach pharmacies. Moreover,
now we will clearly see the movement of medicines in hospitals and clinics,
which eliminates the illegal circulation of free medicines. Proper control in
this area is ensured,» said Kazakh Prime Minister Olzhas Bektenov.
Web-editor: Гайни Жумабек
Related Articles
